Evidence map›Paper›PMID 24900945›Full record

ArticleJournal of bioterrorism & biodefense2013

Challenges and Practices in Building and Implementing Biosafety and Biosecurity Programs to Enable Basic and Translational Research with Select Agents.

Colleen B Jonsson, Kelly Stefano Cole, Chad J Roy, David S Perlin, Gerald Byrne, members of the RBL-NBL Directors Network

Abstract read
In one paragraph

Article in Journal of bioterrorism & biodefense, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Colleen B JonssonDepartment of Microbiology and Immunology, University of Louisville, KY, USA ; Center for Predictive Medicine for Biodefense and Emerging Infectious Diseases, University of Louisville, KY, USA.
Kelly Stefano ColeCenter for Vaccine Research, Regional Biocontainment Laboratory, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA ; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Chad J RoyTulane National Primate Research Center, Regional Biosafety Laboratory, Covington, LA, USA ; Division of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA, USA.
David S PerlinPublic Health Research Institute and UMDNJ Regional Biocontainment Laboratory, New Jersey Medical School-UMDNJ, Newark, NJ, USA.
Gerald ByrneDepartment of Microbiology and Immunology, University of Tennessee, Memphis, TN, USA.
members of the RBL-NBL Directors Network

Funding

IMMUNITY AND LATENCY TO CHLAMYDIAL INFECTIONSR01AI019782 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI BYRNE, GERALD IRWIN · 1985 to 2014
$4.7M
NIAID NIH HHS R01 AI019782
6 · The paper itself

Abstract

Select agent research in the United States must meet federally-mandated biological surety guidelines and rules which are comprised of two main components: biosecurity and biosafety. Biosecurity is the process employed for ensuring biological agents are properly safeguarded against theft, loss, diversion, unauthorized access or use/release. Biosafety is those processes that ensure that operations with such agents are conducted in a safe, secure and reliable manner. As such, a biological surety program is generally concerned with biological agents that present high risk for adverse medical and/or agricultural consequences upon release outside of proper containment. The U.S. Regional and National Biocontainment Laboratories (RBL, NBL) represent expertise in this type of research, and are actively engaged in the development of programs to address these critical needs and federal requirements. While this comprises an ongoing activity for the RBLs, NBLs and other facilities that handle select agents as new guidelines and regulations are implemented, the present article is written with the goal of presenting a simplified yet comprehensive review of these requirements. Herein, we discuss the requirements and the various activities that the RBL/NBL programs have implemented to achieve these metrics set forth by various agencies within the U.S. Federal government.

Identifiers

PMID24900945
PMCPMC4041738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.